| R&D PIPELINE | Development Stage | ||
|---|---|---|---|
| Discovery and Development | Preclinical Research | Clinical Research | |
| COVID-19 Variant-Targeting mRNA Vaccine |
Ongoing Research in Developing mRNA Vaccine Core Technology for Enhanced Antigen Expression |
Preclinical Toxicity Assessment (Targeting Recent Omicron Variants) |
IND Filing (2025-) |
| Self-Amplifying mRNA Vaccine Platform | Basic Research & Preclinical Trial Candidate Selection | ||
| Reverse Genetics-Based Attenuated Vaccine Platform |
Basic Research (COVID-19, Zika, Dengue, etc.) & Preclinical Trial Candidate Selection (Zika virus) |
||
| RNA Therapy: Target Discovery & Design |
Basic Research & Target/Lead Discovery | ||
| Antivirals (Coronaviruses, Flaviviruses, Norovirus) |
RNA Replicase Inhibitors / RNA Therapeutics / mRNA nAbs | Discovery of Preclinical Trial Candidates (2024-) | |